Susan Hasty, Publisher
Table of Contents . . . October 31st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Coinfection - GBV-C inhibition of HIV mediated by CD4 and CD8 T-cell-derived soluble factors
HIV/AIDS HAART - Cotrimoxazole prophylaxis prevents complications prior to HAART initiation
HIV/AIDS HAART - De novo drug-resistance mutations selected during first HAART interruption cycle
HIV/AIDS Prophylaxis - Single-dose nevirapine within 24 hours of birth protects against HIV-1 infection
HIV/AIDS-Related Lipodystrophy - Growth hormone releasing factor improves lipid levels in HIV/AIDS
Antimicrobials - Plant extracts have antimicrobial activity against HIV-related fungal pathogens
DNA Research - HIV-1 Vpr induces degradation of UNG and SMUG uracil-DNA glycosylases
Fungal Infections - Inhaled amphotericin B for pulmonary fungal infections in immunosuppressed patients released
HIV/AIDS Diagnostics - Plasma RT assay is an affordable alternative for HIV viral load determination
HIV/AIDS Drug Development - Protease inhibitors plus mefloquine have marked synergy against HIV-1
HIV/AIDS Drug Monitoring - Therapeutic drug monitoring confirms low atazanavir exposure in some patients
HIV/AIDS Vaccines - Researchers' findings advance HIV/AIDS vaccines research
HIV/AIDS Drug Resistance - Some HIV-1 R5 V3 loop structures acquire resistance to CCR5 binding inhibitors
HIV/AIDS HAART - Protease inhibitors activate the unfolded protein response in macrophages to promote heart disease
HIV/AIDS HAART - Tat mediates sensitivity to reactive drug metabolites in HIV-infected cells
HIV/AIDS HAART Prophylaxis - Adherence to HAART prophylaxis is low in victims of suspected sexual abuse
HIV/AIDS Pathogenesis - HIV Nef induces rapid internalization of CD8 alpha beta
HIV/AIDS Pathogenesis - HIV gp120 stimulates p53 activity and induces Apaf-1 expression in neurons
HIV/AIDS Pathogenesis - HIV mutations during early infection preferentially found in known CTL epitopes
HIV/AIDS Pathogenesis - HIV-1 gp41 (LM)-M-565 mutation stabilizes the coiled-coil structure
HIV/AIDS Pathogenesis - NF-kappa B-repressing factor required for HIV-1 LTR transcriptional activation
HIV/AIDS Pathogenesis - Saliva HIV levels more influenced by blood HIV RNA levels than oral inflammation
HIV/AIDS Pathogenesis - Ubiquitylation of Cdk9 by Skp2 facilitates optimal HIV-1 tat transactivation
HIV/AIDS Pathogenesis - Vpr-mediated cell cycle arrest is important for HIV replication and pathogenesis
HIV/AIDS Testing - Rapid HIV blood test passes Malaysian government evaluation
HIV/AIDS Therapy - Data advance knowledge in HIV/AIDS therapy research
HIV/AIDS Therapy - WHO places another antiretroviral drug on pre-qualification list
HIV/AIDS Transmission Risk - Second trimester amniocentesis does not increase vertical HIV transmission risk
HIV/AIDS Vaccine Development - U.S. NIH launches first phase II trial of HIV/AIDS vaccine
HIV/AIDS Vaccines - Research add new data to HIV/AIDS vaccines body of knowledge
HIV/AIDS-Associated Infection - TSP/HAM should be considered in HIV patients with myelopathy and normal CD4 counts
HIV/AIDS-Related Dementia - GM-CSF leads microglia to specific activation other than giant cell formation
HIV/AIDS-Related Infection - E. coli from AIDS patients in Senegal has low cotrimoxazole susceptibility
HIV/AIDS-Related Infection - HIV-1 infection is not a risk factor for amebiasis
Personnel - STD-focused diagnostics company names its chairman, Roger I. Gale, as interim CEO
Simian Immunodeficiency Virus - Antigenic stimulation reactivates archived SIV gene replication
Vaccine Development - Positive results of gene-based therapies for HIV, vascular disease published
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.